Page 8 - Trinity Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Investment Analysts’ new coverage for Sunday, February 4th: StockNews.com began coverage on shares of ATA Creativity Global (NASDAQ:AACG). The firm issued a sell rating on the stock. StockNews.com began coverage on shares of Atlantic American (NASDAQ:AAME). They issued a hold rating on the stock. StockNews.com initiated coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS). StockNews.com issued […]

Investment Analysts’ new coverage for Sunday, February 4th: StockNews.com began coverage on shares of ATA Creativity Global (NASDAQ:AACG). The firm issued a sell rating on the stock. StockNews.com began coverage on shares of Atlantic American (NASDAQ:AAME). They issued a hold rating on the stock. StockNews.com initiated coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS). StockNews.com issued […]

Trinity Biotech (NASDAQ:TRIB – Get Free Report) released its earnings results on Wednesday. The company reported ($0.18) earnings per share (EPS) for the quarter, reports. The company had revenue of $14.68 million for the quarter. Trinity Biotech Price Performance NASDAQ:TRIB traded up $0.04 on Friday, reaching $0.60. 1,209,407 shares of the company’s stock traded hands, […]

Trinity Biotech plc. paid $12.5 million to acquire Waveform Technologies Inc.’s biosensor and continuous glucose monitoring (CGM) assets. It also formed a partnership with Bayer AG to launch a CGM biosensor in China and India. These moves are part of Trinity’s transformation strategy to become a leading player in wearable biosensor technology.